Stoneridge Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$14.1M |
| 2 |
Johnson & Johnson
JNJ
|
+$12.5M |
| 3 |
Norwegian Cruise Line
NCLH
|
+$9.04M |
| 4 |
Charter Communications
CHTR
|
+$8.81M |
| 5 |
Philip Morris
PM
|
+$8.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum! Brands
YUM
|
+$8.82M |
| 2 |
Edwards Lifesciences
EW
|
+$7.79M |
| 3 |
Hershey
HSY
|
+$6.08M |
| 4 |
Macerich
MAC
|
+$5.81M |
| 5 |
CVS Health
CVS
|
+$5.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.67% |
| 2 | Healthcare | 15.17% |
| 3 | Communication Services | 12.33% |
| 4 | Technology | 11.55% |
| 5 | Consumer Staples | 10.54% |
Similar funds
Stoneridge Investment Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Stoneridge Investment Partners held 360 positions worth $671M, down 9.5% from $741M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Stoneridge Investment Partners withdrew a net $65.8M in Q2 2017, closing 109 positions and reducing 146 holdings. Its most notable exit was Yum! Brands, an estimated $8.82M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Stoneridge Investment Partners opened a new position in Norwegian Cruise Line worth $9.51M.
- Stoneridge Investment Partners's largest Q2 2017 buy was Norwegian Cruise Line: 175,111 shares worth $9.51M.
- Stoneridge Investment Partners added most to Gilead Sciences in Q2 2017, an estimated $14.1M increase.
- Stoneridge Investment Partners's biggest Q2 2017 reduction was CVS Health, cutting an estimated $5.79M.
- Stoneridge Investment Partners fully exited Yum! Brands in Q2 2017, selling an estimated $8.82M.
- Stoneridge Investment Partners's ten largest holdings make up 22% of its $671M portfolio in Q2 2017.
- Stoneridge Investment Partners opened 55 new positions and closed 109 in Q2 2017.
- Stoneridge Investment Partners's portfolio value fell 9.5% quarter-over-quarter to $671M.
Based on Stoneridge Investment Partners's 13F filing for Q2 2017, filed 1 Aug 2017.